There are insufficient data for the COVID-19 Treatment Guidelines Panel (the Panel) to recommend either for or against the use of ivermectin for the treatment of COVID-19. Results from adequately p.
Also found this Ivermectin has been trialled in treating the coronavirus SARS-CoV-2, which is the virus that causes COVID-19. An in vitro trial has shown ivermectin reduces the number of cell-associated viral RNA by 99.8 % in 24 hours. An in vitro study is when they study cells in a laboratory and not in a living organism.
News 
Market Data 
Discover 
